Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University of Jerusalem's Tech Transfer Company, Yissum

The two drug-discovery projects for novel, next generation, innovative, patentable psychedelic compounds, are expected to expand Clearmind’s IP portfolio Tel Aviv, Israel / Vancouver, Canada,... | January 19, 2023

Related Keywords

Boston ,Massachusetts ,United States ,Jerusalem ,Israel General ,Israel ,Canada ,Hebrew University ,Yerushalayim ,Tel Aviv ,Frankfurt ,Brandenburg ,Germany ,Canadian ,Ahmad Masarwa ,Dmitry Tsvelikhovsky ,Adi Zuloff Shani ,Avi Priel ,Clearmind Medicine Inc ,Boston Scientific ,Frankfurt Stock Exchange ,Nasdaq ,Novartis ,Exchange Commission ,Hebrew University Of Jerusalem ,Canadian Securities Exchange ,Johnson ,Intel ,Professor Dmitry Tsvelikhovsky ,Professor Masha Niv ,Professor Avi Priel ,Professor Ahmad Masarwa ,Professor Rami Yaka ,Private Securities Litigation Reform Act ,Clearmind Medicine Inc Stock Exchange ,News ,Information ,Press Release ,The ,Two ,Projects ,Or ,Text ,Npatentable ,Sychedelic ,Fire ,Xpected ,O ,Xpand ,P ,Portfolio ,El ,Srael Cmnd Ca1850532047 ,